斑贴试验知情同意书:EADV接触性皮炎工作组立场声明
欧洲皮肤病与性病学会(EADV)接触性皮炎工作组采用德尔菲调查(2轮问卷加1次最终讨论),由9名欧洲专家就斑贴试验知情同意书应包含的要点达成共识。共识条目涵盖介绍、试验准备、测试流程、允许的活动、不良事件及额外授权等内容,并建议未来推进该同意书的标准化与统一化。
要点
- 斑贴试验知情同意书应涵盖介绍、准备、流程、允许活动、不良事件和额外授权。
- 共识采用德尔菲法,共识定义为中位评分≥7且四分位距≤3。
- 目前尚缺乏斑贴试验知情同意书的国际共识,需推进标准化。
核心结论
- 专家小组就斑贴试验知情同意书应包含的若干主题达成共识,并指出未来需推进该同意书的标准化与统一化。
研究设计与样本
- 采用德尔菲调查,包括2轮问卷和1次最终讨论,通过互联网进行,由9名来自欧洲的EADV接触性皮炎工作组专家参与。
主要发现
- 专家小组讨论了知情同意书应包含的多个主题:介绍、斑贴试验准备、测试流程、允许的活动、不良事件及额外授权。
关键数值与推荐
- 共识定义为中位共识评分(MED)≥7且专家间一致性为四分位距(IQR)≤3。
临床怎么用
- 临床可参考该共识要点完善斑贴试验知情同意书的内容框架。
局限性
- 研究未报告具体的共识条目数值、样本量或P值等细节,且仅基于9名欧洲专家,未来需进一步标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To our knowledge, an international consensus is lacking regarding the development of an adequate informed consent form for a patch test (PT) and the information that should be included in such document. OBJECTIVES: The aim of the study was to reach a consensus on the specific points that need to be addressed in a PT consent form. METHODS: A Delphi survey, comprising 2 rounds and 1 final discussion, was used to gather and analyse data, which was conducted over the Internet. Each statement that reached a consensus with the respondents (9 expert dermatologists from Europe) was defined as a median consensus score (MED) of ≥7 and agreement among panelists as an interquartile range (IQR) of ≤3. All study participants were members of the EADV task force on contact dermatitis. RESULTS: The expert panel addressed several topics that should be included in an informed consent form for a PT: introduction, preparation for PT, testing procedure, allowed activities, adverse events and additional authorizations. CONCLUSIONS: Our results assess recommendations regarding points to be contained in an informed consent form for a PR. Future actions towards standardization and harmonization of this specific consent form are needed.
引用
- Balato A, Scala E, Ayala F, et al. Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis. J Eur Acad Dermatol Venereol. 2021. PMID: 34286888. doi:10.1111/jdv.17483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。